All In MedTech

Device Trial Radar · NCT02698956

SOURCE 3: Observational Study to Evaluate Safety and Performance of SAPIEN 3 THV System in Real Life Practice

Edwards SAPIEN 3 Aortic Bioprosthesis Multi-Region Outcome Registry

Last checked: Nov 20, 2026Latest source record: Mar 16, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,000

Actual

Start

Jul 2014

Primary completion

Feb 2016

Study completion Nov 30, 2020

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
First posted
Mar 4, 2016

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an international, mutli-center, prospective, consecutively enrolled, observational registry. 2000 patients are planned to be enrolled over one year at up to 150 participating sites. 300 patients out of the 2000 patients enrolled in the main registry are planned to be consecutively enrolled in a select few sites for studying the valve performance. Echocardiogram and angiogram will be taken routinely.

Conditions

  • Aortic Stenosis

Interventions

  • TAVI (Transcatheter Aortic Valve Implantation)Device

    Edwards SAPIEN 3 Transcatheter Heart Valve (S3 THV) and Edwards Commander Delivery system (transfemoral) and Certitude Delivery system (transapical/transaortic). The Edwards S3 THV is indicated for use in patients with severe, symptomatic, calcific aortic stenosis with STS Score ≥ 8 or Logistic EuroSCORE ≥15

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All cause mortalityTime frame: 30 days

Locations

73 sites in 10 countries. Site status is shown where the registry gives one.

  • Aarhus University Hospital, Skejby

    Aarhus, Denmark

  • Helsinki University Hospital

    Helsinki, Finland

  • Oulu University Hospital

    Oulu, Finland

70 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.